Cargando…
Is further improvement of the treatment of acute coronary syndromes still possible?
Successful treatment of myocardial infarction related to early reperfusion therapy has caused growing interest in not only ischemic but also myocardial reperfusion injury. Most experimentally confirmed preservation myocardial reperfusion injury methods have failed in clinical practice. Probably one...
Autor principal: | Dąbrowski, Marek Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915943/ https://www.ncbi.nlm.nih.gov/pubmed/24570690 http://dx.doi.org/10.5114/pwki.2013.34027 |
Ejemplares similares
-
Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?
por: Iannetta, Loredana, et al.
Publicado: (2013) -
Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
por: Gąsior, Paweł, et al.
Publicado: (2013) -
Motor Competence in Individuals with Down Syndrome: Is an Improvement Still Possible in Adulthood?
por: Quinzi, Federico, et al.
Publicado: (2022) -
The Hardening Hypothesis: Further Testing Is Still Required
por: Steffensen, Isabella, et al.
Publicado: (2022) -
Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19
por: Grzegorowska, Oliwia, et al.
Publicado: (2020)